Capricor Therapeutics, Inc.CAPRNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+41.1%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+41.1%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.8x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$61.32M+22.7%
2024$49.97M+37.1%
2023$36.45M+67.1%
2022$21.82M-
2021$0.00-
2020$0.00-100.0%
2019$5.14M-
2018$0.00-
2017$0.00-
2016$0.00-